Bradford J Shingleton

Title: Bradford J Shingleton: Innovator in Migraine Treatment

Introduction

Bradford J Shingleton is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of migraines. With a total of 2 patents, his work focuses on innovative compositions and methods that aim to alleviate the suffering caused by this debilitating condition.

Latest Patents

Shingleton's latest patents include groundbreaking methods for treating migraines using prostaglandin F analog compositions. One patent details the use of prostaglandin F2alpha analog compositions for topical administration. This method involves applying a composition containing a prostaglandin F2alpha analog or its pharmaceutically acceptable salt to a subject in need. The treatment can be administered either prophylactically or therapeutically, targeting areas such as the skin, conjunctival surface, or other mucous membranes. The analogs mentioned in his patents include latanoprost, isopropyl unoprostone, bimatoprost, travoprost, and tafluprost.

Career Highlights

Throughout his career, Shingleton has worked with various companies, including Manistee Partners LLC and Manistee Therapeutics, Inc. His experience in these organizations has contributed to his expertise in developing effective migraine treatments.

Collaborations

Shingleton has collaborated with notable professionals in his field, including Robert L Bratzler and Martin Wand. These partnerships have likely enhanced his research and development efforts in migraine treatment.

Conclusion

Bradford J Shingleton is a distinguished inventor whose work in migraine treatment has the potential to improve the quality of life for many individuals. His innovative approaches and collaborations reflect his commitment to advancing medical science.